Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to pr...

por Turcotte, Eric, Wiens, Linda W, Grierson, John R, Peterson, Lanell M, Wener, Mark H, Vesselle, Hubert
Publicado 2007

Assessment of a statistical AIF extraction method for dynamic PET studies with (15)O water and (18)F fluorodeoxyglucose in locally advanced breast cancer patients

por O’Sullivan, Finbarr, O’Sullivan, Janet N., Huang, Jian, Doot, Robert, Muzi, Mark, Schubert, Erin, Peterson, Lanell, Dunnwald, Lisa K., Mankoff, David M.
Publicado 2017

Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer

por Chitalia, Rhea, Viswanath, Varsha, Pantel, Austin R., Peterson, Lanell M., Gastounioti, Aimilia, Cohen, Eric A., Muzi, Mark, Karp, Joel, Mankoff, David A., Kontos, Despina
Publicado 2021

Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer

por Chitalia, Rhea, Viswanath, Varsha, Pantel, Austin R., Peterson, Lanell M., Gastounioti, Aimilia, Cohen, Eric A., Muzi, Mark, Karp, Joel, Mankoff, David A., Kontos, Despina
Publicado 2021

Effect of (18)F-FDG Uptake Time on Lesion Detectability in PET Imaging of Early-Stage Breast Cancer

por Wangerin, Kristen A., Muzi, Mark, Peterson, Lanell M., Linden, Hannah M., Novakova, Alena, O'Sullivan, Finbarr, Kurland, Brenda F., Mankoff, David A., Kinahan, Paul E.
Publicado 2015

Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer

por Kazerouni, Anum S., Peterson, Lanell M., Jenkins, Isaac, Novakova-Jiresova, Alena, Linden, Hannah M., Gralow, Julie R., Hockenbery, David M., Mankoff, David A., Porter, Peggy L., Partridge, Savannah C., Specht, Jennifer M.
Publicado 2023

Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

por Kurland, Brenda F, Gadi, Vijayakrishna K, Specht, Jennifer M, Allison, Kimberly H, Livingston, Robert B, Rodler, Eve T, Peterson, Lanell M, Schubert, Erin K, Chai, Xiaoyu, Mankoff, David A, Linden, Hannah M
Publicado 2012

(18)F-fluorodeoxyglucose (FDG) PET or (18)F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-...

por Romine, Perrin E., Peterson, Lanell M., Kurland, Brenda F., Byrd, Darrin W., Novakova-Jiresova, Alena, Muzi, Mark, Specht, Jennifer M., Doot, Robert K., Link, Jeanne M., Krohn, Kenneth A., Kinahan, Paul E., Mankoff, David A., Linden, Hannah M.
Publicado 2021